** See Disclosure Requirements Statement Below **

Headquarters

  220 Superior Boulevard
  Mississauga, Ontario  L5T 2L2
  Toll Free: 888.363.3112
    (Canada/US only)
  Phone: 905.670-4428
  Fax: 905.670-4749



Press Releases


May 17, 2012

MUNKNEE.COM: This Skin Cancer Detection Device Could Be a Great Investment in Your Health – and Your Wealth


May 16, 2012

MoleMate “Optical Biopsy” Poised to Improve The Quality of Care for Patients with Moles


May 7, 2012

MedX Reports Year End Financials and Record Fourth Quarter Sales


April 19, 2012

MedX Granted Additional US and Australian Patents For the Use of Light to Visualize Structures Within Skin


April 12, 2012

MedX Committed to Skin Cancer Patient Awareness


April 2, 2012

MedX Health Announces Non-Brokered Private Placement


March 23, 2012

Skin Cancer Imaging with MoleMate Featured at American Academy of Dermatology Meeting


March 20, 2012

MedX Health Corp. Enters China – One of the World’s Largest and Fastest Growing Medical Device Markets


March 9, 2012

New Video Examines the Improvement In the Quality of Care of Patients For the Early Detection of Skin Cancer With MoleMate


March 5, 2012

Skin Cancer Imaging with MoleMate™ Accelerates New Revenue Growth Strategy Via Entry Into Multiple Hundred Million Dollar Markets and On-Line Services


February 29, 2012

Senior Management Agree to Debt Settlement Of $1.3 Million at Significant Prices Over Market


February 8, 2012

Health Canada Approves Skin Cancer Imaging System, MoleMate™


November 14, 2011

MedX Announces ScreenCancer AS


September 21, 2011

Innovative Skin Imaging System, MoleMate™ FDA Approved and Now Available in the US


June 14, 2011

MedX Health Announces Agreement for Acquisition of Worldwide Assets of Innovative Skin Imaging System, MoleMate™


January 12, 2011

MedX Health Announces US Agreement for Innovative Skin Analysis System, MoleMate™


September 30, 2010

MedX Health Corp.’s RJ-Laser Veterinary Products Selected by Vet Novations Canada


 


Simsys Molemate by MedX
Medx Health Simsys Molemate
SIMSYS-MoleMate • MoleMate is a non-invasive, rapid, and painless melanoma screening device that has been specifically designed with and for Dermatologists, General Practitioners and skin specialists. SIMSYS is an image management system with enhanced lesion visualization and comprehensive patient image & data storage capabilities. For more information, please go to Simsys-Molemate.com or watch SIMSYS-MoleMate video

Live life's many adventures free of pain...

MedX Product Overview Strains & Sprains, Tendonitis, Arthritis, Back pain...
All debilitating conditions that make life experiences challenging and painful. Now there is a fast, drug free, non-invasive solution to help you get back to enjoying the many pleasures of life -- MedX Phototherapy.

MedX speeds the body's natural repair response to reduce pain and accelerate healing. ...more information




Smoking & Addiction Training Programs

Advanced Training in Low Level Laser TherapyMedX Acupuncture Console







MedX Health's Presentation...

"The Healing Nature of Light"



Corporate Spotlight

American Executive - Steve Guillen on MedX Health Corporation: Lighting the Way


Steve Guillen - MedX President & CEO

Steve Guillen, President
and CEO

Practical Applications

Arthritis, Strains & Sprains
Carpal Tunnel Syndrome
Dental Pain and Tissue Repair


FAQs and More

Frequently Asked Questions & Other Website References
MedX Electronics Quality Policy

 

Request More Information


Medical Professionals
Patient Inquiries


Certificates & Registration


MedX CE Approval Certificate
CE Approval Certificate

MedX ISO Certificate
ISO Certificate

MedX Warranty Registration
Warranty Registration





Locate a MedX Phototherapy Clinic near you...


Copyright© 2010 MedX Health™ 220 Superior Blvd., Mississauga, Ontario Canada L5T 2L2

Disclosure Requirements Statement: Effective February 12, 2008, MedX is a public company whose shares are listed and trading on the TSX Venture Exchange under the symbol "MDX". As a consequence, this site will be undergoing reconstruction to accommodate the disclosure requirements of Canadian securities laws and regulations.

The MoleMate and SIMSYS products described herein incorporates copyright protection technology that is protected by method and device claims of certain U.S. and Worldwide patents and other intellectual property rights owned by MedX Health Corp., and other rights owners. Use of this copyright protection technology must be authorized by MedX Health Corp.and is intended for clinical and other limited viewing uses only unless otherwise authorized by MedX Health Corp. Reverse engineering or disassembly is prohibited.

Method and apparatus Claims of U.S. and Worldwide Patent numbers: US6324417, US7916910, US2008075340, WO9822023, WO0075637, EP2393063, EP1768060, EP1185853, EP1006876, JP4856872, JP2001504020, JP2003501651, JP2007190364, GB2334099, GB2367125, GB2429385, GB2439469, CA2272290, CA2560364, AU2006220441, AU2006220441, AU4961597, AU5232100, AU725766 licensed for limited viewing uses only.  Back to top